1Degeare VS, Dangas G, Stone GW, et al. Interventional procedures in acute myocardial infarction [J]. Am Heart J, 2001,141(1):15-24.
2Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab,in acute myocardial infarction[J]. N Engl J Med, 2002,346 (13) : 957- 966.
3Marx SO, Marks AR. The development of rapamyein and its application to stent restenosis[J]. Circulation, 2001,104 (8) : 852-855.
4Guagliumi G, Farb A, Musumeci G, et al. Sirolimus-eluting stent implanted in human coronary artery for 16 months pathological findings[J]. Circulation,2003,107(9):1340-1341.
5Mckeage K, Murdoch D, Goa KL. The sirolimus-eluting stent ,a review of its use in trentment of coronary artery disease[J]. Am J Cardiovasc Drugs, 2003,3 (3) : 211-230.
6Saia F, Lemos PA, Lee CH, et al. Comparison between sirolimus-eluting stems and conventional interventional strategies for patients with acute myocardial infarction-results of the RESEARCH registry[J]. Circulation, 2003, 108 (15) : 1890-1891.
7Lemos PA, Saia F, Hofma SH, et al. Short-and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction[J].J Am Coil Cardiol,2004,43(4) :704-708.
8Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model[J]. Circulation,2001,104(10) :1188-1193.
9Virmani R, Farb A, Guagliumi G, et al. Drug-eluting stents: caution and concerns for long-term outcome [ J ]. Coronary Artery Disease, 2004,15 (6) .- 313-318.
10Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents:a review of available cases from the Research on Adverse Drug Events and Reports(RADAR) project[J]. J Am Coll Cardiol,2006,47(1) : 175-181.
